Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 38821-52-2
2. Indoramin Hcl
3. Baratol
4. N-(1-(2-(1h-indol-3-yl)ethyl)piperidin-4-yl)benzamide Hydrochloride
5. Doralese
6. Wy-21,901 Hcl
7. N-[1-[2-(1h-indol-3-yl)ethyl]piperidin-4-yl]benzamide;hydrochloride
8. Dq0z3k8w92
9. N-(1-(2-indol-3-ylethyl)-4-piperidyl)benzamide Monohydrochloride
10. Benzamide, N-(1-(2-(1h-indol-3-yl)ethyl)-4-piperidinyl)-, Monohydrochloride
11. Dsstox_cid_26504
12. Dsstox_rid_81673
13. Dsstox_gsid_46504
14. Indoramin Hydrochloride (usan)
15. Vidora
16. Wydora
17. Baratol (pharmaceutical)
18. Indoramin Hydrochloride [usan]
19. Cas-38821-52-2
20. Ncgc00165810-01
21. Indoramin Hydrochloride [usan:ban]
22. Einecs 254-136-2
23. Indoraminhydrochloride
24. Unii-dq0z3k8w92
25. Indoramine Hydrochloride
26. N-(1-(2-(1h-indol-3-yl)ethyl)-4-piperidinyl)benzamide Hydrochloride
27. Schembl123678
28. Chembl2104941
29. Dtxsid1046504
30. Indoramin Hydrochloride [mi]
31. Tox21_112265
32. Mfcd00242842
33. Akos016011220
34. N-[1-[2-(1h-indol-3-yl)ethyl]-4-piperidinyl] Benzamide Hydrochloride
35. Tox21_112265_1
36. Indoramin Hydrochloride [mart.]
37. Indoramin Hydrochloride [who-dd]
38. Ncgc00165810-02
39. D04532
40. Q27276533
| Molecular Weight | 383.9 g/mol |
|---|---|
| Molecular Formula | C22H26ClN3O |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 5 |
| Exact Mass | 383.1764402 g/mol |
| Monoisotopic Mass | 383.1764402 g/mol |
| Topological Polar Surface Area | 48.1 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 454 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
52
PharmaCompass offers a list of Indoramin Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Indoramin Hydrochloride manufacturer or Indoramin Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Indoramin Hydrochloride manufacturer or Indoramin Hydrochloride supplier.
PharmaCompass also assists you with knowing the Indoramin Hydrochloride API Price utilized in the formulation of products. Indoramin Hydrochloride API Price is not always fixed or binding as the Indoramin Hydrochloride Price is obtained through a variety of data sources. The Indoramin Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Indoramin HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Indoramin HCl, including repackagers and relabelers. The FDA regulates Indoramin HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Indoramin HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Indoramin HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Indoramin HCl supplier is an individual or a company that provides Indoramin HCl active pharmaceutical ingredient (API) or Indoramin HCl finished formulations upon request. The Indoramin HCl suppliers may include Indoramin HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Indoramin HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Indoramin HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Indoramin HCl active pharmaceutical ingredient (API) in detail. Different forms of Indoramin HCl DMFs exist exist since differing nations have different regulations, such as Indoramin HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Indoramin HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Indoramin HCl USDMF includes data on Indoramin HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Indoramin HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Indoramin HCl suppliers with USDMF on PharmaCompass.
Indoramin HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Indoramin HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Indoramin HCl GMP manufacturer or Indoramin HCl GMP API supplier for your needs.
A Indoramin HCl CoA (Certificate of Analysis) is a formal document that attests to Indoramin HCl's compliance with Indoramin HCl specifications and serves as a tool for batch-level quality control.
Indoramin HCl CoA mostly includes findings from lab analyses of a specific batch. For each Indoramin HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Indoramin HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Indoramin HCl EP), Indoramin HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Indoramin HCl USP).